No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
No Data
10-Q: Q3 2024 Earnings Report
8-K: Barinthus Bio Reports Third Quarter 2024 Update on Corporate Developments and Financial Results
10-Q: Q2 2024 Earnings Report
8-K: Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results
Express News | Vaccitech PLC - Pipeline Prioritization Is Expected to Result in a Reduction in Workforce of Approximately 25%